Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Apr. 30, 2020
Apr. 30, 2019
Current Assets    
Cash $ 236,668 $ 503,438
Inventory 78,650
Other 3,020 100,000
Total Current Assets 318,338 603,438
Goodwill 2,466,073
Trademark 20,000
Other 3,853
TOTAL ASSETS 2,808,264 603,438
Current Liabilities    
Accounts payable 249,050 20,894
Accrued Expenses 89,342 15,116
Notes Payable 118,771
Due to Related Party 333,684
Customer deposits 38,419  
Common shares to be issued 754,700
Total Current Liabilities 829,266 790,710
Convertible debentures 450,000
Commitments and contingencies
Stockholders' Equity    
Series A Preferred Stock - shares authorized 2,200,000; outstanding 208,704 and 0; Series B Preferred Stock - shares authorized 4,300,000; outstanding 3,681,623 and 0 38,903
Common stock - shares authorized 500,000,000; outstanding 20,011,091 and 179,292 20,011 179
Additional paid-in capital 4,043,837 784,371
Accumulated deficit (2,573,753) (971,822)
Total Stockholders' Equity 1,528,998 (187,272)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,808,264 $ 603,438